News

Treatment —— Minimize harm to patients

IResounding Success of IWD-HIFU 2022: Nearly 150 Hospitals Participated the World's Third Multicenter

Themed on Empowering Women Health through Technology, the World’s Third Multicenter Telemedicine Womb-preserving Campaign brought to a successful conclusion on March 7, 2022. The Campaign was co-hosted by the State Key Laboratory of Ultrasound in Medicine and Engineering of China (SKLUME), the National Engineering Research Center of Ultrasound Medicine of China (NERCUM) and the International Society of Minimally Invasive and Virtual Surgery (ISMIVS) in Liangjiang District, Chongqing, China, attracting 147 global HIFU centres to join online and together deliver HIFU treatment, an innovative noninvasive therapy, for women with uterine fibroids and/or adenomyosis. The Campaign also witnessed the world’s first trans-provincial HIFU surgery using 5G technology.